Tolicyclidine
| 3-Me-PCPy | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 243.4 g/mol [1] |
| Predicted LogP | 3.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H25N [1] |
| IUPAC name | 1-[1-(3-methylphenyl)cyclohexyl]pyrrolidine [1] |
| SMILES | CC1=CC(=CC=C1)C2(CCCCC2)N3CCCC3 [1] |
| InChI | InChI=1S/C17H25N/c1-15-8-7-9-16(14-15)17(10-3-2-4-11-17)18-12-5-6-13-18/h7-9,14H,2-6,10-13H2,1H3 [1] |
| InChIKey | JZVMREFYFTZXGN-UHFFFAOYSA-N [1] |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 9 mg(10x - 37%) |
| Common | 9 - 10 mg(6x - 22.2%) |
| Strong | 10 - 14 mg(5x - 18.5%) |
| Heavy | 14 - 17.5 mg(2x - 7.4%) |
| Extreme | 17.5 mg +(4x - 14.8%) |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Tolicyclidine (also known as 3-Methyl-pcpy, 3-Me-pcpy or 1-(1-(3-Methylphenyl)cyclohexyl)pyrrolidine) is a
Chemistry
Stereochemistry []
Tolicyclidine is a achiral mixture.
Subjective effects []
| 0xea / Tolicyclidine [] | |
|---|---|
Routes:
| |
Experience reports []
There are currently 4 experience reports involving tolicyclidine on Erowid:
Legal status []
- Canada: Tolicyclidine is a Schedule I substance.
- United Kingdom: Tolicyclidine is a Class B substance.
- Germany: Tolicyclidine is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 137332188, 3-Methyl-pcpy. Accessed May 14, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/137332188
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Tolicyclidine. UNII: FS9Z5C7CQ5. Global Substance Registration System. Accessed May 14, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/FS9Z5C7CQ5